Your browser doesn't support javascript.
loading
How do we manage t(11;14) plasma cell disorders with venetoclax?
Chakraborty, Rajshekhar; Bhutani, Divaya; Lentzsch, Suzanne.
Affiliation
  • Chakraborty R; Multiple Myeloma and Amyloidosis Program, Columbia University Irving Medical Center, New York, New York, USA.
  • Bhutani D; Multiple Myeloma and Amyloidosis Program, Columbia University Irving Medical Center, New York, New York, USA.
  • Lentzsch S; Multiple Myeloma and Amyloidosis Program, Columbia University Irving Medical Center, New York, New York, USA.
Br J Haematol ; 199(1): 31-39, 2022 10.
Article in En | MEDLINE | ID: mdl-35594184
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraproteinemias / Antineoplastic Agents Type of study: Clinical_trials / Guideline Limits: Humans Language: En Journal: Br J Haematol Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraproteinemias / Antineoplastic Agents Type of study: Clinical_trials / Guideline Limits: Humans Language: En Journal: Br J Haematol Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido